PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Sep 2005 (Vol:2005, Issue: 63)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Antipodean Innovation Published: 1 Sep-2005
By: Fintan Walton
Abstract Fulltext:
Section: Deal Trackers
Abatacept Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Purdue Pharma to Market Labopharm’s Once-Daily Tramadol in the US Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
AstraZeneca and Early-Stage Deal Making Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Biogen Idec and PDL: Licensing Triumphs over Acquisition Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Baltic States Bring Biotech Expertise to Enlarged Europe Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Rheumatoid Arthritis Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Adherex Transformed by Deal with GSK Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Bavarian Nordic AS Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Sereno and Genmab Partner Again with a US$215 M Deal Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
OSI to Buy Eyetech for US$935 M Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
PLIVA’s Odyssey Pharmaceuticals Continues Divestment Spree Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
UCB and Imclone Strike Antibody Alliance Published: 5 Sep-2005
By: Business Review Editor
Abstract Fulltext:

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Table of Contents

Login

Bookmarks